AC Immune Ltd
Biotechnology
Healthcare
ACIU
101 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
2.14
52 week high
3.78
high
2.19
52 week low
1.48
low
2.01
growth
-34.91 %
previous Close
2.11
P/E ratio
market cap
265 M
div yield
0
usd
Sep 2024
qoq
revenue
25.49 M
3.00 %
net incoming
5.50 M
124.18 %
eps
0.00 %
126.09 %
eps surprise
126.09 %
net profit margin
21.59 %
3334.00 %
operating incoming
7.27 M
134.68 %
net change in cash
-19.15 M
-571.59 %
cash on hand
32.42 M
-37.13 %
cost of revenue
0.00 %
top top